Anzeige
Mehr »
Mittwoch, 11.02.2026 - Börsentäglich über 12.000 News
Drohnen, Robotik, E-Autos: Diese Hightech-Aktie könnte jetzt zünden
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3D3XY | ISIN: US92919Y1029 | Ticker-Symbol:
NASDAQ
11.02.26 | 18:41
0,316 US-Dollar
-6,26 % -0,021
Branche
Software
Aktienmarkt
Sonstige
1-Jahres-Chart
VSEE HEALTH INC Chart 1 Jahr
5-Tage-Chart
VSEE HEALTH INC 5-Tage-Chart
ACCESS Newswire
516 Leser
Artikel bewerten:
(2)

VSee Health Appeals NASDAQ Staff Delisting Notice

SAN JOSE, CA / ACCESS Newswire / August 12, 2025 / VSee Health, Inc. (Nasdaq:VSEE) (the "Company"), a leader in telehealth solutions, today announced that it has requested a hearing before a Nasdaq Listing Qualifications Panel to appeal an earlier Staff Determination to delist the Company's common stock from the Nasdaq Capital Market.

VSee Health received a letter from the Nasdaq Stock Market ("Nasdaq") on August 5th, 2025 indicating that the Company did not comply with the NASDAQ's filing requirements because it had not filed its Annual Report on Form 10-K for period ending December 31, 2024, and its Quarterly Report on Form 10-Q for the period ending March 31, 2025. Following procedures set forth in the Nasdaq rules, VSee Health has requested a hearing before a Nasdaq Listing Qualifications Panel (the "Panel") to review the Staff Determination. The appeal will automatically stay the delisting for 15 days. The Company plans to request a further stay pending the hearing, which, if approved, would allow the Company to continue to trade on the Nasdaq Capital Market. There can be no assurance however, that the Panel will grant the Company request for continued listing on the Nasdaq Capital Market or such extended stay.

In the event that the Panel denies the Company's request for continued listing on the Nasdaq Capital Market, the Company's common stock could be eligible to trade on the OTC Bulletin Board.

About VSee Health

VSee Health, Inc. (Nasdaq:VSEE) is a leading provider of telehealth solutions, specializing in real-time virtual care, clinical review, and billing services. Its technology powers healthcare networks and organizations worldwide, enabling seamless patient-provider interactions and ensuring efficient care delivery. Field-hardened on over 1.5M HIPAA-compliant video encounters every month, VSee Health's highly scalable, customizable telehealth building blocks each meet stringent security standards. VSee Health has deployed services in over 50 countries, including Iraq, Syria, Marshall Islands and El Salvador. Its clients include NASA, US Department of Health and Human Services, McKesson, Magellan, DaVita, GE, countless startups, and the entire country of Qatar. VSee Health also provides tailored solutions for critical shortage areas such as critical care and teleradiology. VSee Health is committed to empowering high quality healthcare access and reducing physician burnout and workforce shortages through its telehealth technology. For more information, please visit www.vseehealth.com.

Forward-Looking Statements

Matters discussed in this news release that are not statements of historical or current facts, including but not limited to those relating to VSee Health's ability to improve healthcare access and provider efficiencies, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause performance or achievements to be materially different from historical results or from any future performance or achievements expressed or implied by such forward-looking statements. Accordingly, readers should not place undue reliance on any forward-looking statements. More information on risk factors relating to VSee Health and its technology and billing services is included from time to time in the "Cautionary Note Regarding Forward-Looking Statements," "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of VSee Health's periodic and current filings with the SEC, which are also made available on VSee Health's website at www.vseehealth.com. Forward-looking statements speak only as of the date they are made, and VSee Health undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise that occur after that date, or otherwise. Readers are cautioned not to put undue reliance on forward-looking statements.

Contact:

VSee Health
Anne Chang
media@vsee.com

VSee Investor Contact:
Milton Chen
VSee Health
investor@vsee.com

SOURCE: VSee Health, Inc.



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/vsee-health-appeals-nasdaq-staff-delisting-notice-1059862

© 2025 ACCESS Newswire
Favoritenwechsel
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.